Signature Therapeutics' Merger

Signature Therapeutics raised a round of funding on January 19, 2016. Investors include Ensysce Biosciences.

Signature Therapeutics, formerly PharmacoFore, is a biopharmaceutical company focused on creating medicines to improve upon the therapeutic utility of existing drugs, enhance patient care, and prevent…

Articles about Signature Therapeutics' Merger: